Artificial Pancreas Device System Market Research by Key Types and Major Application, Analysis and Forecasts Till 2030

 Artificial Pancreas Device System Market Overview:

The first artificial pancreas, Medtronic’s MiniMed 670G System was approved by the US FDA in 2016 after years of tremendous strides made in the R&D of artificial pancreas device system. An artificial pancreas device system is intended to automatically monitor blood sugar level and accordingly modify basal insulin dose in patients with type 1 diabetes. The Global Artificial Pancreas Device System Market Share is likely to tread forward at a CAGR of 21.10% over the forecast period of 2023-2030, asserts Market Research Future (MRFR) in an in-depth study.

Towering cases of pancreatic ailments and surge in the number of patients diagnosed with diabetes have increased substantially in recent years. The situation is further aggravated by sedentary lifestyle, unhealthy dietary habits, obesity and lack of exercise which augments the need for autonomous glycemic control. Moreover, an increase in geriatric population acts a plus for the market since they are more prone to pancreatic disorders. Expanding healthcare budgets and growing inflow of investment in the market is favoring the growth of the global artificial pancreas device system market. In addition, numerous projects are underway in which massive investments have been poured in to check the feasibility of these devices in hospital setting which is likely to augur the growth of the market.

Furthermore, recent years have witnessed a surge in the number of FDA approvals for artificial pancreas device systems. The FDA is collaborating with medical device manufacturers, academic institutions, and diabetes care providers to foster innovation and expedite further development of the technology which is expected to boost the market growth over the forecast period. The global artificial pancreas device system market is expected to reach USD 341.08 Mn by the end of the forecast period.

Competitive Landscape:

The notable players in the global Artificial Pancreas Device System Market include Johnson & Johnson, Tandem Diabetes Care Inc., Medtronic Plc, Inreda Diabetic B.V., Insulet Corp, Beta Bionics, Dexcom Inc., F. Hoffmann-La Roche Ltd., Bigfoot Biomedical, TypeZero Technologies LLC,

Cellnovo, and Pancreum Inc.

Segmentation:

The global artificial pancreas device market has been segmented based on type and end user.

By type, the global artificial pancreas device market has been segmented into CTT (Control To Target) Systems and CTR (Control to Range) Systems

By end user, the global artificial pancreas device market has been segmented into hospitals and medical centers.

Regional Analysis:

By region, the global artificial pancreas device system market has been segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa (MEA).

The Americas, North America in particular, is leading the global artificial pancreas device system market. Robust healthcare infrastructure and high healthcare expenditure and fast uptake of the latest technologies in the region can be credited for the growth of the market.

Europe too is a significant market for artificial pancreas. Government funding for R&D, high healthcare expenditure and the presence of sophisticated healthcare infrastructure support market growth.

APAC is slated to showcase rapid growth over the forecast period due to high healthcare expenditure in the emerging economies such as China and India. The MEA market is expected to showcase limited growth owing to weak economic conditions and low healthcare penetration.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Comments

Post a Comment

Popular posts from this blog

Kidney Stone Market Key Developments Trends, Global Key Vendors, Analysis and Forecasts Till 2027

  Kidney Stone Market Overview: Market Research Future (MRFR) report states that the global  kidney stones market size  is set to cross the valuation of 2,508.01 million by 2027. The market will progress at an impressive growth rate during the forecast period (2023-2030). Kidney stone market has observed a stable growth rate over the past few years, with the trend set to continue further on account of increasing prevalence and recurrence rate of kidney stones globally. Other protuberant factors associated with the market growth include growing demand for minimally invasive procedures and the burgeoning population along with poor nutrition. Global Kidney Stone Market – Competitive Dashboard The key players in this market are Boston Scientific Corp., C.R. Bard Inc., Convergent Laser Technologies, Cook Medical Inc., DirexGroup, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., Elmed Electronics & Medical Industry & Trade Inc., Medispec Ltd., Olympus Corp., Richard Wolf Gm
Read more

Sterility Testing Market Trends, Revenue, Shares and Demand Forecasts to 2030

  Sterility Testing Market Overview: The global sterility testing market size is expected to touch USD 1,245.2 million by 2023 owing to rising sales of cars. Market Research Future’s (MRFR) latest study reveals that the market is predicted an 11.7% CAGR during the forecast period (2017–2023). High prevalence of chronic diseases and cardiovascular maladies is the primary factor driving market growth. Booming pharmaceutical and biotechnology sectors, funding provided by governments, and rising investments in the life science sector are other factors expected to elicit market demand over the forecast period. Demand for sterile drugs is creating opportunities for manufacturers and distributors. In addition, demand for effective vaccines to combat chronic maladies is anticipated to bode well for the market. Development of filtration systems to expedite drug development can positively impact the market. For instance, Merck launched the Steric up Quick Release system in 2017 for faster filtra
Read more

Immunoassay Market Sparkling Key Players Shares, Revenue, Analysis and Forecasts to 2030

  Market Highlights The global  immunoassay market size  accounted for USD 18,626.7 million in 2022 and is projected to register a CAGR of 5.9% over the forecast period. Immunoassay is a biochemical test that relies on biochemistry to measure the presence and concentration of an analyte (protein, lipid, nucleic acid, among others) in solution (serum, urine, etc.) by using antibody-antigen reactions. Some of the factors characterizing the market growth are rising R&D expenditure in the healthcare sector, rising prevalence of chronic and infectious diseases, increasing adoption of immunoassay, technological advancements in immunoassay instruments and the introduction of novel automated systems, and surging elderly population across the world. For instance, the World Health Organization (WHO) reported that global elderly population was 841.0 million in 2013, increased to 962.3 million in 2022, which is projected to reach more than 2.0 billion by the end of 2050. In contrast, limitatio
Read more